Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mary V Relling

Showing results (141-150 of 295) with videos related to

Pageof 30
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 7, 2012
Proximal tubular secretion of creatinine by organic cation transporter OCT2 in cancer patientsGiuliano Ciarimboli, Cynthia S Lancaster, Eberhard Schlatter, et al.
Pharmacogenetics|November 20, 2002
Genetic polymorphisms in CYP3A5, CYP3A4 and NQO1 in children who developed therapy-related myeloid malignanciesJavier G Blanco, Mathew J Edick, Michael L Hancock, et al.
Cancer|May 12, 2017
Palmar-plantar erythrodysesthesia syndrome following treatment with high-dose methotrexate or high-dose cytarabineSeth E Karol, Wenjian Yang, Colton Smith, et al.
Pediatrics|June 24, 2016
Pharmacogenetics for Safe Codeine Use in Sickle Cell DiseaseRoseann S Gammal, Kristine R Crews, Cyrine E Haidar, et al.
British Journal of Haematology|July 20, 2016
Klinefelter syndrome and 47,XYY syndrome in children with B cell acute lymphoblastic leukaemiaRachel E Rau, Andrew J Carroll, Nyla A Heerema, et al.
Human Genetics|April 1, 2003
Polymorphisms in the MLL breakpoint cluster region (BCR)Deborah R Echlin-Bell, Lydia L Smith, Loretta Li, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|July 22, 2016
Standardizing terms for clinical pharmacogenetic test results: consensus terms from the Clinical Pharmacogenetics Implementation Consortium (CPIC)Kelly E Caudle, Henry M Dunnenberger, Robert R Freimuth, et al.
Blood|August 19, 2006
Body mass index does not influence pharmacokinetics or outcome of treatment in children with acute lymphoblastic leukemiaNobuko Hijiya, John C Panetta, Yinmei Zhou, et al.
Cancer|January 19, 2012
Resumption of high-dose methotrexate after acute kidney injury and glucarpidase use in pediatric oncology patientsAnthony M Christensen, Jennifer L Pauley, Alejandro R Molinelli, et al.
Plos One|August 8, 2015
Antileukemic Efficacy of Continuous vs Discontinuous Dexamethasone in Murine Models of Acute Lymphoblastic LeukemiaLaura B Ramsey, Laura J Janke, Monique A Payton, et al.
Pageof 30

Showing results (141-150 of 295) with videos related to

Sort By:
Pageof 30
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 7, 2012
Proximal tubular secretion of creatinine by organic cation transporter OCT2 in cancer patientsGiuliano Ciarimboli, Cynthia S Lancaster, Eberhard Schlatter, et al.
Pharmacogenetics|November 20, 2002
Genetic polymorphisms in CYP3A5, CYP3A4 and NQO1 in children who developed therapy-related myeloid malignanciesJavier G Blanco, Mathew J Edick, Michael L Hancock, et al.
Cancer|May 12, 2017
Palmar-plantar erythrodysesthesia syndrome following treatment with high-dose methotrexate or high-dose cytarabineSeth E Karol, Wenjian Yang, Colton Smith, et al.
Pediatrics|June 24, 2016
Pharmacogenetics for Safe Codeine Use in Sickle Cell DiseaseRoseann S Gammal, Kristine R Crews, Cyrine E Haidar, et al.
British Journal of Haematology|July 20, 2016
Klinefelter syndrome and 47,XYY syndrome in children with B cell acute lymphoblastic leukaemiaRachel E Rau, Andrew J Carroll, Nyla A Heerema, et al.
Human Genetics|April 1, 2003
Polymorphisms in the MLL breakpoint cluster region (BCR)Deborah R Echlin-Bell, Lydia L Smith, Loretta Li, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|July 22, 2016
Standardizing terms for clinical pharmacogenetic test results: consensus terms from the Clinical Pharmacogenetics Implementation Consortium (CPIC)Kelly E Caudle, Henry M Dunnenberger, Robert R Freimuth, et al.
Blood|August 19, 2006
Body mass index does not influence pharmacokinetics or outcome of treatment in children with acute lymphoblastic leukemiaNobuko Hijiya, John C Panetta, Yinmei Zhou, et al.
Cancer|January 19, 2012
Resumption of high-dose methotrexate after acute kidney injury and glucarpidase use in pediatric oncology patientsAnthony M Christensen, Jennifer L Pauley, Alejandro R Molinelli, et al.
Plos One|August 8, 2015
Antileukemic Efficacy of Continuous vs Discontinuous Dexamethasone in Murine Models of Acute Lymphoblastic LeukemiaLaura B Ramsey, Laura J Janke, Monique A Payton, et al.
Pageof 30